Vernal Keratoconjunctivitis Market to Surge with Biologic Therapy Innovations
Vernal keratoconjunctivitis (VKC) is a severe, recurrent allergic inflammation of the ocular surface predominantly affecting children and young adults. Treatments include topical antihistamines, mast cell stabilizers, corticosteroids, and the latest biologics targeting IgE and interleukins. These products offer advantages such as rapid symptom rel